InvestorsHub Logo
Followers 13
Posts 2195
Boards Moderated 0
Alias Born 05/30/2012

Re: misiu143 post# 167724

Tuesday, 05/25/2021 2:51:35 PM

Tuesday, May 25, 2021 2:51:35 PM

Post# of 233375
He is not mistaken, that is the treatment protocol for the 594 patient moderate trial.

Yup, they are doing a phase 3 that follows the patient population that benefitted most in CD10.

NP covering all bases.

Lot of potential here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News